InMode (INMD) News Today $18.90 -0.07 (-0.37%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$18.90 0.00 (-0.03%) As of 02/21/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period InMode Ltd. (NASDAQ:INMD) Shares Sold by Meitav Investment House Ltd.Meitav Investment House Ltd. lowered its stake in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 1.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,334,405 shares of the healthcare company's stockFebruary 21 at 6:09 AM | marketbeat.com50,799 Shares in InMode Ltd. (NASDAQ:INMD) Acquired by Atlas Legacy Advisors LLCAtlas Legacy Advisors LLC acquired a new position in InMode Ltd. (NASDAQ:INMD - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 50,799 shares of the healthcare company's stock, valueFebruary 19 at 5:56 AM | marketbeat.comShort Interest in InMode Ltd. (NASDAQ:INMD) Rises By 6.0%InMode Ltd. (NASDAQ:INMD - Get Free Report) was the recipient of a large increase in short interest in January. As of January 31st, there was short interest totalling 6,050,000 shares, an increase of 6.0% from the January 15th total of 5,710,000 shares. Based on an average trading volume of 959,300 shares, the short-interest ratio is currently 6.3 days.February 18, 2025 | marketbeat.comInMode Ltd. (NASDAQ:INMD) Stock Holdings Lessened by DDD Partners LLCDDD Partners LLC lessened its holdings in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 46.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 606,965 shares of the healthcare company's stock after sellingFebruary 17, 2025 | marketbeat.comInMode (NASDAQ:INMD) Shares Gap Down - Here's WhyInMode (NASDAQ:INMD) Shares Gap Down - Here's WhyFebruary 15, 2025 | marketbeat.comInMode Ltd. (NASDAQ:INMD) Q4 2024 Earnings Call TranscriptFebruary 11, 2025 | msn.comInMode: Plastic Surgery Boom, Cash Flow, And CheapFebruary 10, 2025 | seekingalpha.comInMode (INMD) Q4 2024 Earnings Call TranscriptFebruary 6, 2025 | msn.comInMode Ltd. (INMD) Q4 2024 Earnings Call TranscriptFebruary 6, 2025 | seekingalpha.comEarnings call transcript: InMode Q4 2024 results miss forecastsFebruary 5, 2025 | msn.comInMode price target raised to $29 from $26 at BarclaysFebruary 5, 2025 | markets.businessinsider.comBarclays Increases InMode (NASDAQ:INMD) Price Target to $29.00Barclays lifted their price objective on shares of InMode from $26.00 to $29.00 and gave the company an "overweight" rating in a research note on Wednesday.February 5, 2025 | marketbeat.comInMode (INMD) Receives a Hold from NeedhamFebruary 4, 2025 | markets.businessinsider.comBTIG Remains a Buy on InMode (INMD)February 4, 2025 | markets.businessinsider.comInMode (NASDAQ:INMD) Updates FY25 Earnings GuidanceInMode (NASDAQ:INMD) updated its FY25 earnings guidance. The company provided EPS guidance of $1.95-$1.99 for the period, compared to the consensus estimate of $1.98. The company also issued revenue guidance of $395-$405 millionillion, compared to the consensus estimate of $413.47 millionillion.February 4, 2025 | marketbeat.comInMode's (INMD) Hold Rating Reiterated at Needham & Company LLCNeedham & Company LLC reiterated a "hold" rating on shares of InMode in a research report on Tuesday.February 4, 2025 | marketbeat.comInMode LTD.: InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase ProgramFebruary 4, 2025 | finanznachrichten.deInMode announces new share repurchase programFebruary 4, 2025 | markets.businessinsider.comInMode reports revenue dip, plans share repurchaseFebruary 4, 2025 | msn.comInMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase ProgramFebruary 4, 2025 | prnewswire.comInMode (INMD) to Release Quarterly Earnings on TuesdayInMode (NASDAQ:INMD) will be releasing earnings before the market opens on Tuesday, February 11, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=655257)February 4, 2025 | marketbeat.comInMode Ltd. (NASDAQ:INMD) Shares Sold by Boston Trust Walden CorpBoston Trust Walden Corp reduced its position in InMode Ltd. (NASDAQ:INMD - Free Report) by 2.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,367,376 shares of the healthcare company's stock after selling 40,695 shares durFebruary 4, 2025 | marketbeat.comInMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools ConferenceFebruary 3, 2025 | prnewswire.comINMD Makes Bullish Cross Above Critical Moving AverageFebruary 1, 2025 | nasdaq.comSG Americas Securities LLC Cuts Stake in InMode Ltd. (NASDAQ:INMD)SG Americas Securities LLC reduced its stake in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 39.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,541 shares of the healthcaJanuary 30, 2025 | marketbeat.comInMode: A Clear Bargain With Unique RisksJanuary 28, 2025 | seekingalpha.comInMode Ltd. (NASDAQ:INMD) Given Average Recommendation of "Hold" by BrokeragesInMode Ltd. (NASDAQ:INMD - Get Free Report) has received a consensus recommendation of "Hold" from the six research firms that are covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation toJanuary 28, 2025 | marketbeat.comInMode (NASDAQ:INMD) earnings and shareholder returns have been trending downwards for the last three years, but the stock rallies 5.1% this past weekJanuary 20, 2025 | uk.finance.yahoo.comInMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally AnnouncedJanuary 16, 2025 | prnewswire.comDOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share BuybackJanuary 15, 2025 | prnewswire.comInMode Faces Macroeconomic Challenges and Manufacturing Disruptions, Leading to Hold RatingJanuary 11, 2025 | markets.businessinsider.comInMode: Clearly, I Was Too Optimistic (Rating Downgrade)January 10, 2025 | seekingalpha.comJPMorgan Chase & Co. Sells 145,448 Shares of InMode Ltd. (NASDAQ:INMD)JPMorgan Chase & Co. cut its stake in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 12.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,038,603 shares of the healthcare company's stock after selling 145,448 shJanuary 10, 2025 | marketbeat.comBarclays Cuts InMode (NASDAQ:INMD) Price Target to $26.00Barclays decreased their target price on InMode from $27.00 to $26.00 and set an "overweight" rating for the company in a research report on Thursday.January 9, 2025 | marketbeat.comNeedham Remains a Hold on InMode (INMD)January 9, 2025 | markets.businessinsider.comInMode price target lowered to $26 from $27 at BarclaysJanuary 9, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: InMode (INMD) and Sana Biotechnology (SANA)January 8, 2025 | markets.businessinsider.comInMode (NASDAQ:INMD) Shares Gap Down - Here's What HappenedInMode (NASDAQ:INMD) Shares Gap Down - Should You Sell?January 8, 2025 | marketbeat.comInMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5MJanuary 8, 2025 | prnewswire.comInMode Ltd. (NASDAQ:INMD) Given Consensus Rating of "Hold" by AnalystsInMode Ltd. (NASDAQ:INMD - Get Free Report) has earned a consensus recommendation of "Hold" from the six brokerages that are presently covering the stock, Marketbeat reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 monthJanuary 3, 2025 | marketbeat.comWith 57% institutional ownership, InMode Ltd. (NASDAQ:INMD) is a favorite amongst the big gunsDecember 30, 2024 | finance.yahoo.comInMode Ltd. (NASDAQ:INMD) Shares Bought by Barclays PLCBarclays PLC increased its holdings in InMode Ltd. (NASDAQ:INMD - Free Report) by 113.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 169,630 shares of the healthcare company's stock after buying an additional 90,173 shares during the period. Barclays PLCDecember 25, 2024 | marketbeat.comInMode Ltd. (NASDAQ:INMD) Stock Holdings Increased by State Street CorpState Street Corp raised its holdings in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 3.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,044,640 shares of the healthcare company's stock after buying an additional 73,183December 21, 2024 | marketbeat.comShort Interest in InMode Ltd. (NASDAQ:INMD) Decreases By 8.2%InMode Ltd. (NASDAQ:INMD - Get Free Report) saw a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 5,910,000 shares, a decrease of 8.2% from the November 15th total of 6,440,000 shares. Based on an average daily volume of 1,160,000 shares, the short-interest ratio is presently 5.1 days.December 16, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stock Position in InMode Ltd. (NASDAQ:INMD)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 54.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 125,480 shares of the hDecember 16, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Reduces Stake in InMode Ltd. (NASDAQ:INMD)The Manufacturers Life Insurance Company lowered its stake in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 95.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,646December 16, 2024 | marketbeat.com34,718 Shares in InMode Ltd. (NASDAQ:INMD) Bought by Vestcor IncVestcor Inc bought a new position in shares of InMode Ltd. (NASDAQ:INMD - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 34,718 shares of the healthcare company's stock, valued at approximately $588,000. A number of otherDecember 13, 2024 | marketbeat.comInMode: Product Origination And Undervaluation Make The Stock A BuyDecember 12, 2024 | seekingalpha.comThe Returns On Capital At InMode (NASDAQ:INMD) Don't Inspire ConfidenceDecember 9, 2024 | uk.finance.yahoo.comInMode Ltd. (NASDAQ:INMD) Receives Average Rating of "Hold" from AnalystsInMode Ltd. (NASDAQ:INMD - Get Free Report) has received a consensus recommendation of "Hold" from the six brokerages that are currently covering the firm, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. TheDecember 9, 2024 | marketbeat.com Get InMode News Delivered to You Automatically Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter. Email Address INMD Media Mentions By Week INMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INMD News Sentiment▼1.630.60▲Average Medical News Sentiment INMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INMD Articles This Week▼56▲INMD Articles Average Week Get InMode News Delivered to You Automatically Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NARI News NVST News PRCT News IRTC News WRBY News LIVN News ENOV News NVCR News TMDX News LMAT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INMD) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.